G0070 HCPCS Reimbursement & Policy Benchmarks

HCPCS Level II code G0070 denotes professional administration of intravenous chemotherapy or other highly complex intravenous drugs or biological infusions delivered in the patient's home, reported per infusion drug administration calendar day in 15-minute units. This code captures home-based infusion care where skilled clinical staff provide medication administration and monitoring—services that enable complex cancer and specialty drug therapies outside hospital or clinic settings. Nationally, home infusion services are increasingly important for patient convenience, capacity management in acute care settings, and care continuity for high-acuity therapies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of clinical context for home intravenous infusion, common billing and service characteristics tied to G0070, and concise benchmarking and policy considerations relevant to payers and provider organizations. The publication summarizes typical sites of service, coding implications for per-day and per-15-minute reporting, and what to expect in payer coverage scope at a national level. Data not available in the input for specific associated taxonomies, ICD-10 diagnoses, or related codes is noted where applicable.

Billing Code Overview

HCPCS Level II code G0070 describes professional services for administration of intravenous chemotherapy or other highly complex intravenous drug or biological infusion provided in the patient's home. The service is reported for each infusion drug administration calendar day and is billed in 15-minute increments.

Service type: Intravenous chemotherapy / highly complex drug or biological infusion administration

Typical site of service: Patient's home (home health / in-home care setting)

Clinical Context

A 62-year-old woman with metastatic colorectal cancer receives home-based intravenous chemotherapy infusions administered by a qualified oncology nurse under the direction of an oncologist. The patient has a tunneled central venous catheter and is scheduled for a 90-minute infusion of a highly complex biologic agent on Mondays. A nurse documents pre-infusion assessment (vital signs, line patency check, allergy review), prepares and administers the drug using infusion pump settings, monitors for infusion-related reactions during each 15-minute billing increment, and completes post-infusion patient education and documentation. The professional service billed under G0070 captures the nurse/clinician time for each 15-minute interval of professional administration on that calendar day in the patient’s home.

Typical workflow:

Referral and clinical order placed by treating oncologist.
Home infusion agency schedules visit, verifies medication and infusion plan, and confirms patient identity and consent.
Nurse arrives at home, performs pre-infusion assessment, documents baseline status, and establishes infusion equipment.
Drug is administered via infusion pump; nurse monitors patient and documents each 15-minute block of professional infusion time for G0070 billing.
Post-infusion assessment, disposal of sharps/medication waste, instructions provided, and clinical documentation transmitted to ordering oncologist.

Typical site of service: Patient’s home (home health / home infusion setting).

Service type: Professional administration of intravenous chemotherapy or other highly complex IV biologic/infusion, billed per 15-minute interval per infusion drug administration calendar day using .

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the professional component of a service if applicable in a split-service scenario for interpretation or oversight related to infusion management.
`52`	Reduced services	Use when the infusion professional service was partially reduced or discontinued early for documented clinical reasons.
`53`	Discontinued procedure	Use when the infusion is started but terminated due to patient emergency or adverse event before planned completion.
`54`	Surgical care only	Rare for `G0070`; use if only the surgical component is billed by a surgeon and professional infusion services are furnished by another provider.
`55`	Postoperative management only	Not typical for `G0070`; apply only if billing relates strictly to post-op care distinct from infusion administration.
`56`	Preoperative management only	Not typical; use when only pre-procedure evaluation related to infusion is billed separately.
`62`	Two surgeons	Uncommon for home infusion; use if two physicians of different specialties share operative responsibilities related to access placement preceding home infusion.
`78`	Unplanned return to the operating room	Use if an unplanned operative intervention is required related to infusion access complications—rarely paired with `G0070`.
`22`	Increased procedural services	Use when documentation supports substantially greater work, time, or complexity for the professional infusion service provided at home.
`23`	Unusual anesthesia	Use when unusual anesthesia unrelated to the infusion itself is required and documented.
`59`	Distinct procedural service	Not provided in input modifiers list; not included.

Taxonomy Code	Specialty	Notes
`364A00000X`	Infusion Nurse	Nurses specializing in home infusion therapy, IV access management, and chemotherapy administration.
`207L00000X`	Medical Oncology	Oncologists who authorize, supervise, and manage chemotherapy regimens delivered in the home.
`207K00000X`	Hematology/Oncology	Specialists managing complex biologic and chemotherapeutic infusion protocols.
`363LP0808X`	Home Health Agency	Providers coordinating and delivering home-based skilled nursing infusion services.
`333600000X`	Clinical Pharmacist	Pharmacists involved in chemotherapy preparation, dose verification, and drug safety oversight.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C78.7`	Secondary malignant neoplasm of liver and intrahepatic bile duct	Metastatic disease often requiring systemic chemotherapy or biologic infusions administered at home for palliation or disease control.
`C80.1`	Malignant (primary) neoplasm, unspecified — often used for widespread metastatic cancer	Indicates advanced cancer where home infusion of chemotherapy or complex biologics may be provided for symptom control or systemic therapy.
`C50.912`	Malignant neoplasm of unspecified site of right female breast, unspecified — example primary cancer	Breast cancer patients commonly receive IV chemotherapy or targeted biologic infusions in home infusion programs when clinically appropriate.
`C34.90`	Malignant neoplasm of unspecified part of unspecified bronchus or lung	Lung cancer patients may receive systemic intravenous therapies at home for tolerability and convenience.
`D61.9`	Aplastic anemia, unspecified	Some hematologic conditions requiring complex biologic infusions or supportive IV therapies may be administered at home under careful monitoring.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96413`	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug	Often performed in-clinic; when patients receive initial or clinic-based infusions, `96413` is the comparable CPT for IV chemotherapy administration; home infusion professional time is reported with `G0070` instead.
`96415`	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary infusion)	In clinic settings this reports additional infusion hours; in home setting `G0070` provides 15-minute billing increments for professional infusion time instead.
`96365`	Intravenous infusion, therapeutic, prophylactic, or diagnostic; initial, up to 1 hour	For non-chemotherapy IV infusions in ambulatory settings and may precede or complement home infusion planning when care transitions occur.
`36415`	Collection of venous blood by venipuncture	Performed prior to infusion for labs such as CBC, metabolic panel; may be done in home prior to chemotherapy administration.
`96374`	Therapeutic, prophylactic, or diagnostic injection (specify substance and route of administration); each additional sequential infusion of a new drug via central line, per day	Used when multiple IV infusions of different drugs are given sequentially in outpatient settings; in the home, professional time for each drug administration calendar day is captured with `G0070`.

OpenPayer

Summary & Overview

HCPCS G0070: Home Intravenous Chemotherapy / Complex Drug Infusion Administration